Heart Disease Trial, Recruiting NCT05312164 Sponsor: Gentuity, LLC Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT05312164
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years of age
  • People who are willing and able to give written consent to participate
  • People who have symptoms or signs that suggest possible coronary artery (heart) disease
  • People who are being considered for a procedure to open blocked heart arteries (called PCI) and are already scheduled for a heart catheter procedure, where a pressure-based test to measure blood flow through narrowed arteries may be performed if the treating doctor considers it appropriate

Who may not be able to join:

  • People who are having a certain type of serious heart attack (called STEMI) at the time of the catheter procedure
  • People for whom the pressure-based blood flow test (FFR) or the medications used during it are not medically suitable
  • People who have a bacterial infection in their bloodstream or a life-threatening infection (sepsis)
  • People who have significant problems with their blood's ability to clot normally
  • People who have severely unstable blood pressure or are in circulatory shock
  • People who have the most severe stage of heart failure (confirm with trial site)
  • People who have severe disease affecting the valves of the heart
  • People who have previously had a heart transplant
  • People who have acute kidney failure at the time of screening, as determined by their treating doctor
  • People who are pregnant
  • People who are currently taking part in another clinical study that could affect the results of this trial
  • People who have other serious health conditions that, in the opinion of the study doctor, could affect their participation (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 978-202-4108

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Gentuity, LLC
Registry
ClinicalTrials.gov
Start date
14 March 2022
Est. completion
31 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Collection of angiography images, HF-OCT images, and FFR pressure wire data

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov